Cargando…

Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis

BACKGROUND: Globally, sickle cell disease (SCD) is one of the most common haemoglobinopathy. Considered a public health problem, it leads to vessel occlusion, blood stasis and chronic activation of the coagulation system responsible for vaso-occlussive crises and venous thromboembolism (VTE) which m...

Descripción completa

Detalles Bibliográficos
Autores principales: Noubiap, Jean Jacques, Temgoua, Mazou N., Tankeu, Ronni, Tochie, Joel Noutakdie, Wonkam, Ambroise, Bigna, Jean Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171302/
https://www.ncbi.nlm.nih.gov/pubmed/30305805
http://dx.doi.org/10.1186/s12959-018-0179-z
_version_ 1783360767386451968
author Noubiap, Jean Jacques
Temgoua, Mazou N.
Tankeu, Ronni
Tochie, Joel Noutakdie
Wonkam, Ambroise
Bigna, Jean Joël
author_facet Noubiap, Jean Jacques
Temgoua, Mazou N.
Tankeu, Ronni
Tochie, Joel Noutakdie
Wonkam, Ambroise
Bigna, Jean Joël
author_sort Noubiap, Jean Jacques
collection PubMed
description BACKGROUND: Globally, sickle cell disease (SCD) is one of the most common haemoglobinopathy. Considered a public health problem, it leads to vessel occlusion, blood stasis and chronic activation of the coagulation system responsible for vaso-occlussive crises and venous thromboembolism (VTE) which may be fatal. Although contemporary observational studies suggest a relationship between SCD or sickle trait (SCT) and VTE, there is lack of a summary or meta-analysis data on this possible correlation. Hence, we propose to summarize the available evidence on the association between SCD, SCT and VTE including deep vein thrombosis (DVT) and pulmonary embolism (PE). METHODS: We searched PubMed and Scopus to identify all cross-sectional, cohort and case-control studies reporting on the association between SCD or SCT and VTE, DVT or PE in adults or children from inception to April 25, 2017. For measuring association between SCD or SCT and VTE, DVT, or PE, a meta-analysis using the random-effects method was performed to pool weighted odds ratios (OR) of risk estimates. RESULTS: From 313 records initially identified from bibliographic databases, 10 studies were eligible and therefore included the meta-analysis. SCD patients had significantly higher risk for VTE (pooled OR 4.4, 95%CI 2.6–7.5, p < 0.001), DVT (OR 1.1, 95% CI 1.1–1.2, p < 0.001) and PE (pooled OR 3.7, 95% CI 3.6–3.8, p < 0.001) as compared to non SCD-adults. A higher risk of VTE (OR 33.2, 95% CI 9.7–113.4, p < 0.001) and DVT (OR 30.7, 95% CI 1.6–578.2, p = 0.02) was found in pregnant or postpartum women with SCD as compared to their counterparts without SCD. Compared to adults with SCT, the risk of VTE was higher in adults with SCD (pooled OR 3.1, 95% CI 1.8–5.3, p < 0.001), and specifically in SCD pregnant or postpartum women (OR 20.3, 95% CI 4.1–102, p = 0.0003). The risk of PE was also higher in adults with SCD (OR 3.1, 95% CCI 1.7–5.9, p = 0.0004) as compared to those with SCT. The risk of VTE was higher in individuals with SCT compared to controls (pooled OR 1.7, 95% CI 1.3–2.2, p < 0.0001), but not in pregnant or postpartum women (OR 0.9, 95% CI 0.3–2.9, p = 0.863). Compared to controls, SCT was associated with a higher risk of PE (pooled OR 2.1, 95% CI 1.2–3.8, p = 0.012) but not of DVT (pooled OR 1.2, 95% CI 0.9–1.7, p = 0.157). CONCLUSION: Individuals with SCD, especially pregnant or postpartum women, might have a higher risk of VTE compared to the general population. SCT might also increases the risk of VTE. However, currently available data are not sufficient to allow a definite conclusion. Further larger studies are needed to provide a definitive conclusion on the association between SCD, SCT and VTE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12959-018-0179-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6171302
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61713022018-10-10 Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis Noubiap, Jean Jacques Temgoua, Mazou N. Tankeu, Ronni Tochie, Joel Noutakdie Wonkam, Ambroise Bigna, Jean Joël Thromb J Research BACKGROUND: Globally, sickle cell disease (SCD) is one of the most common haemoglobinopathy. Considered a public health problem, it leads to vessel occlusion, blood stasis and chronic activation of the coagulation system responsible for vaso-occlussive crises and venous thromboembolism (VTE) which may be fatal. Although contemporary observational studies suggest a relationship between SCD or sickle trait (SCT) and VTE, there is lack of a summary or meta-analysis data on this possible correlation. Hence, we propose to summarize the available evidence on the association between SCD, SCT and VTE including deep vein thrombosis (DVT) and pulmonary embolism (PE). METHODS: We searched PubMed and Scopus to identify all cross-sectional, cohort and case-control studies reporting on the association between SCD or SCT and VTE, DVT or PE in adults or children from inception to April 25, 2017. For measuring association between SCD or SCT and VTE, DVT, or PE, a meta-analysis using the random-effects method was performed to pool weighted odds ratios (OR) of risk estimates. RESULTS: From 313 records initially identified from bibliographic databases, 10 studies were eligible and therefore included the meta-analysis. SCD patients had significantly higher risk for VTE (pooled OR 4.4, 95%CI 2.6–7.5, p < 0.001), DVT (OR 1.1, 95% CI 1.1–1.2, p < 0.001) and PE (pooled OR 3.7, 95% CI 3.6–3.8, p < 0.001) as compared to non SCD-adults. A higher risk of VTE (OR 33.2, 95% CI 9.7–113.4, p < 0.001) and DVT (OR 30.7, 95% CI 1.6–578.2, p = 0.02) was found in pregnant or postpartum women with SCD as compared to their counterparts without SCD. Compared to adults with SCT, the risk of VTE was higher in adults with SCD (pooled OR 3.1, 95% CI 1.8–5.3, p < 0.001), and specifically in SCD pregnant or postpartum women (OR 20.3, 95% CI 4.1–102, p = 0.0003). The risk of PE was also higher in adults with SCD (OR 3.1, 95% CCI 1.7–5.9, p = 0.0004) as compared to those with SCT. The risk of VTE was higher in individuals with SCT compared to controls (pooled OR 1.7, 95% CI 1.3–2.2, p < 0.0001), but not in pregnant or postpartum women (OR 0.9, 95% CI 0.3–2.9, p = 0.863). Compared to controls, SCT was associated with a higher risk of PE (pooled OR 2.1, 95% CI 1.2–3.8, p = 0.012) but not of DVT (pooled OR 1.2, 95% CI 0.9–1.7, p = 0.157). CONCLUSION: Individuals with SCD, especially pregnant or postpartum women, might have a higher risk of VTE compared to the general population. SCT might also increases the risk of VTE. However, currently available data are not sufficient to allow a definite conclusion. Further larger studies are needed to provide a definitive conclusion on the association between SCD, SCT and VTE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12959-018-0179-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-04 /pmc/articles/PMC6171302/ /pubmed/30305805 http://dx.doi.org/10.1186/s12959-018-0179-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Noubiap, Jean Jacques
Temgoua, Mazou N.
Tankeu, Ronni
Tochie, Joel Noutakdie
Wonkam, Ambroise
Bigna, Jean Joël
Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
title Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
title_full Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
title_fullStr Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
title_full_unstemmed Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
title_short Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
title_sort sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171302/
https://www.ncbi.nlm.nih.gov/pubmed/30305805
http://dx.doi.org/10.1186/s12959-018-0179-z
work_keys_str_mv AT noubiapjeanjacques sicklecelldiseasesickletraitandtheriskforvenousthromboembolismasystematicreviewandmetaanalysis
AT temgouamazoun sicklecelldiseasesickletraitandtheriskforvenousthromboembolismasystematicreviewandmetaanalysis
AT tankeuronni sicklecelldiseasesickletraitandtheriskforvenousthromboembolismasystematicreviewandmetaanalysis
AT tochiejoelnoutakdie sicklecelldiseasesickletraitandtheriskforvenousthromboembolismasystematicreviewandmetaanalysis
AT wonkamambroise sicklecelldiseasesickletraitandtheriskforvenousthromboembolismasystematicreviewandmetaanalysis
AT bignajeanjoel sicklecelldiseasesickletraitandtheriskforvenousthromboembolismasystematicreviewandmetaanalysis